Where Zimmer Biomet Holdings Stands With Analysts
Portfolio Pulse from Benzinga Insights
In the last quarter, Zimmer Biomet Holdings (NYSE:ZBH) received 1 bullish, 1 somewhat bullish, and 4 indifferent analyst ratings. Over the past 3 months, 6 analysts have offered 12-month price targets for ZBH, with an average price target of $125.33, a 15.32% decrease from the previous average price target of $148.00.
November 09, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Zimmer Biomet Holdings received mixed analyst ratings in the last quarter, with an average price target of $125.33, representing a 15.32% decrease from the previous average price target.
The mixed analyst ratings indicate uncertainty about the company's future performance. The decrease in the average price target suggests that analysts have lowered their expectations for the company's stock price, which could potentially impact investor sentiment and the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100